The Female Health Company was established in the mid 1990s on the strength of world product rights to develop FEMIDOM® - a highly effective, state-of-the-art female condom. It has received a Queen's Award for Enterprise in recognition of the product's contribution to International Trade, an achievement in which PA Consulting Group, the leading international management, systems and technology consultancy, was key.
The Award recognizes The Female Health Company's achievement in developing, producing and marketing a product which has resulted in substantial and sustained growth in the company's overseas sales, (84% over the last three years). PA helped the company take FEMIDOM®, from small scale 'hand fabrication' to high volume manufacture and 100% testing in a 40,000 sq ft facility located in Park Royal, London.
PA's unique blend of medical device industry knowledge and innovative product and process development, enabled the company to design and develop bespoke manufacturing, assembly and testing equipment for such a state-of-the art product.
Ian Rhodes, Partner in Product and Process Engineering at PA's Cambridge Technology Centre and FEMIDOM® team leader, comments:
"This revolutionary product required an equally revolutionary manufacturing process and associated automation. It had to be taken from the production level of 'a few hundred a day' for clinical trial evaluation to '500,000 units a week' - a challenge requiring a highly experienced development team".
Michael Pope, General Manager of The Female Health Company comments:
"PA assessed the initial product design and materials for manufacturing development, and undertook a machine design study to assess different automation concepts. Over a 3 year period, PA assisted us with a number of key tasks including: the recruitment of senior manufacturing staff; the specification and procurement of equipment to operate at unrivalled levels of integrity and speed; equipment testing and assembly; the establishment of current good manufacturing practice (cGMP); and full equipment validation to enable FDA approval at the first attempt".
FEMIDOM is currently available in over 70 countries around the world.
-Ends-